CHELSEA WOOD: Open Payments
NPI 1063931202 · COVINGTON, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 24 payments from 11 companies in 2025. Trend: 2023 $228 · 2024 $665 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $156 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
| Novo Nordisk Inc | 2 | $53 |
| Amgen Inc. | 3 | $52 |
| Mallinckrodt Hospital Products Inc. | 2 | $52 |
| Lilly USA, LLC | 1 | $26 |
| Fresenius USA Marketing, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $17 |
| Apellis Pharmaceuticals, Inc. | 1 | $16 |
Products named: FARXIGA, JYNARQUE, Ozempic, KRYSTEXXA, ACTHAR, JARDIANCE, VELPHORO, IBSRELA.
Industry payments across LA — which companies pay providers there.
